Published May 22, 2003 | Version v1
Patent Open

N4 virion single-stranded DNA dependent RNA polymerase

Contributors

Patent applicant:

Description

A histidine-tagged, deletion mutant of bacteriophage N4-coded, virion RNA polymerase (mini-vRNAP) which is active has been developed. The his-tagged mini-vRNAP has been cloned under the control of the pBAD promoter, is stable and is purified in a single step yielding large amounts (10 mg/liter of E. coli expressing cells). This RNA polymerase uses single-stranded DNA containing 17 bases (the promoter) upstream of the transcribed regions as a template. In the presence of E. coli SSB protein, it transcribes this template efficiently, providing a unique system to synthesize RNAs of the desired sequence using single-stranded DNA templates. The enzyme incorporates derivatized nucleoside triphosphates with high efficiency. A mutant of mini-vRNAP has been generated that incorporates deoxynucleoside triphosphates. In addition, the inventors have developed an in vivo system to express RNAs and proteins under mini vRNA polymerase promoter control.

Files

US7452705.pdf

Files (3.9 MB)

Name Size Download all
md5:21eec02a5bdf312d5939037cd65d6086
3.9 MB Preview Download

Additional details

Identifiers

Patent number
US 15321902 A
Patent application number
US 2003/0096349 A1
Other
oai:uchicago.tind.io:8965

Dates

Patent filed
2002-05-22

UChicago Information

Division(s)
Physical Sciences Division
Department(s)
Physics